 |
 Video: What is a Stock Split?
|
|
|
| Sunesis Pharmaceuticals is a biopharmaceutical company focused on the development of targeted inhibitors for the treatment of hematologic and solid cancers. Co.'s primary activities are conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology and conducting clinical trials. Co.'s primary program is vecabrutinib, a selective non-covalent inhibitor of Bruton's Tyrosine Kinase. Co. is also developing SNS-510, a phosphoinositide-dependent kinase-1 inhibitor licensed from Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited. According to our SNSS split history records, SNSS has had 4 splits. | |
|
SNSS (SNSS) has 4 splits in our SNSS split history database. The first split for SNSS took place on February 14, 2011. SNSS's second split took place on February 15, 2011. This was a 1 for 6 reverse split, meaning for each 6 shares of SNSS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. SNSS's third split took place on September 08, 2016. This was a 1 for 6 reverse split, meaning for each 6 shares of SNSS owned pre-split, the shareholder now owned 1 share. For example, a 166.666666666667 share position pre-split, became a 27.7777777777778 share position following the split. SNSS's 4th split took place on September 03, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of SNSS owned pre-split, the shareholder now owned 1 share. For example, a 27.7777777777778 share position pre-split, became a 2.77777777777778 share position following the split.
When a company such as SNSS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SNSS split history from start to finish, an original position size of 1000 shares would have turned into 2.77777777777778 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SNSS shares, starting with a $10,000 purchase of SNSS, presented on a split-history-adjusted basis factoring in the complete SNSS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/21/2015 |
|
| End date: |
02/24/2021 |
|
| Start price/share: |
$139.80 |
|
| End price/share: |
$5.32 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.19% |
|
| Average Annual Total Return: |
-41.49% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$380.56 |
|
| Years: |
6.10 |
|
|
|
| Date |
Ratio |
| 02/14/2011 | 1 for 1 | | 02/15/2011 | 1 for 6 | | 09/08/2016 | 1 for 6 | | 09/03/2020 | 1 for 10 |
|
|
Free SNSS Email Alerts:
